LipoScience Announces Agreement with Scripps Health to Place Vantera Clinical Analyzer within Scripps Health Facilities

LipoScience

today announced an agreement to place the Vantera® Clinical Analyzer within Scripps Health facilities. The agreement, which marks the first placement of the Vantera Clinical Analyzer in the state of California, will make NMR lipoprotein testing on the analyzer accessible to customers of Scripps Health. The Vantera Clinical Analyzer can identify and quantify concentrations of lipoproteins using NMR spectroscopy and proprietary signal processing algorithms. Such analysis provides the concentration of low-density lipoprotein particles (LDL-P) and other lipoprotein information from a simple blood test. LDL-P is the first FDA-cleared assay on the Vantera Clinical Analyzer and a key component of LipoScience's NMR LipoProfile® test. Adoption and decentralization of the Vantera Clinical Analyzer into clinical laboratories will ultimately provide widespread access to the NMR LipoProfile test, reduce sample processing turnaround time and provide value to physicians focused on delivering quality patient care and personalized management of CVD. To date, over 10 million NMR LipoProfile tests have been ordered. "LDL particle number is increasingly understood to be a more